Digital ‘scripts’ on NHS App
23/04/2024
No Comments
Millions of people will now be able to use the NHS App to view their prescriptions for the first time. Following a successful trial last
Menu
Millions of people will now be able to use the NHS App to view their prescriptions for the first time. Following a successful trial last
Leading experts are calling for glucose monitoring technology – which is currently only available in the UK to people on intensive insulin therapy – to
The US Food and Drug Administration (FDA) is warning against the use of smartwatches and rings that claim to measure glucose levels without piercing the
Team AB The UK Association for Medical Device Approved Bodies, or Team AB, has been formally launched with the aim of helping industry participants navigate
Charlie Cawsey has announced that it has reduce all prices for Type 1 Style CGM stickers and soft toys that wear CGMs. Website creator Cawsey
Following a successful trial, Sweatcoin, a health and fitness app, is being prescribed to people at risk of developing Type 2 diabetes across south west
While diabetes has traditionally been the focus of blood glucose management, Afon Technology is encouraging a shift to a broader perspective. The company believes that
Welcome to our February issue 2024 – with spring on the horizon, it’s nice to look ahead, which we do a fair bit of here.
SiBionics has announced that it has received CE mark approval in Europe for its GS1 continuous glucose monitoring (CGM) system. The company designed its CGM
A patient-facing voice-based conversational artificial intelligence (VBAI) application that provided autonomous basal insulin titration has been found to improve time to optimal insulin dosing, insulin
